TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Unilabs Laboratoriemedisin AS
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
14,533
|
17,390
|
15,494 |
Financial expenses |
281
|
168
|
175 |
Earnings before taxes |
399
|
909
|
2,160 |
Total assets |
10,829
|
13,631
|
9,363 |
Current assets |
4,328
|
6,102
|
5,040 |
Current liabilities |
3,980
|
4,762
|
5,268 |
Equity capital |
3,407
|
3,254
|
2,406 |
- share capital |
34
|
36
|
34 |
Employees (average) | 79 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
31.5%
|
23.9%
|
25.7% |
Turnover per employee | 220 | ||
Profit as a percentage of turnover |
2.7%
|
5.2%
|
13.9% |
Return on assets (ROA) |
6.3%
|
7.9%
|
24.9% |
Current ratio |
108.7%
|
128.1%
|
95.7% |
Return on equity (ROE) |
11.7%
|
27.9%
|
89.8% |
Change turnover |
-1,944
|
1,054
|
578 |
Change turnover % |
-12%
|
6%
|
4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.